A new drug can prevent heart attacks and strokes by cutting bad cholesterol levels, scientists have found.
An international trial of 27,000 patients found that those who took the drug evolocumab saw their bad cholesterol levels fall by about 60% on average.
The patients in the trial were already taking statins, which are used to reduce low-density lipoprotein (LDL) cholesterol. Despite this, the patients who took injections of evolocumab saw their bad cholesterol levels fall even further. They were also less likely to suffer from a heart attack or stroke than those who took the placebo.
The study found that for every 74 people who took the drug for two years, one heart attack or stroke would be prevented.
No comments:
Post a Comment